Adolescent and Young Adult (AYA) Cancer Program Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT03468075
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Adolescent and Young Adult (AYA) Cancer Program

Active Ingredients

Drugs in Phase 2 Trials (2)

gemcitabine (gemzar) (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteosarcoma (Phase 2)

Sarcoma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2